-The Economic Times MUMBAI: India, the world's largest exporter of morphine sulphate, has very little of the drug to offer its terminally ill patients suffering from cancer and HIV. The supply of morphine, a narcotic pain reliever used for treating pain, is severely constrained in local hospitals and retail stores due to stringent laws that prevent and hinder companies from making and transporting the final product. Morphine sulphate is a byproduct of...

-Pratirodh.com NAPM on Tuesday started a three-day demonstration at Jantar Mantar in Delhi to protest against the draft Land Acquisition Bill and demanded revision of the draft to incorporate changes suggested by a Parliamentary panel and civil society.   NAPM has organised the dharna in association with several other land rights and anti-displacement movements — like the National Forum of Forest people,Mazdoor Kisan Shakti Sangathan  and Forest workers — under the banner of...

-The Hindu The debate on the pros and cons of genetically engineered/modified crops is universal. In India, in the face of vociferous protests, the controversy has only deepened leading to a moratorium on cultivation of Bt Brinjal crop — the first GM food crop sought to be commercialised. Gargi Parsai spoke to Basudeb Acharia, Chairman of the Parliamentary Standing Committee on Agriculture, on its new report, “Cultivation of Genetically Modified Food...

-Pratirodh Bureau Activists led by Narmada Bachao Andolan leader Medha Patkar have alleged that the much awaited Land Acquisition Bill was actually a "diluted version" of the Standing Committee's recommended bill.   The activists under belonging to various groups, including National Alliance of People’s Movements, National Forum of Forest people and Forest Workers, Kisan Sangharsh Samiti and Sangharsh claimed that the "positive" position taken by the Standing Committee had been diluted by the...

-The Business Standard State must get out of insulin price-setting The National Pharmaceutical Pricing Authority, or NPPA, has turned down the request of drug companies to raise insulin prices. Domestic insulin-makers Biocon and Cadila had argued that the cost of production and packaging had become higher, and multinational corporation Eli Lilly wanted the depreciation in the rupee vis-à-vis the dollar to be factored into the price. The NPPA says it has...